Special Organic Chemistry Seminar
Noyes 153 (J. Holmes Sturdivant Lecture Hall)
Development of Plant Manufacturing Processes of Key Intermediates for HCV Drug Candidate Telaprevir
Gerald J. Tanoury,
Chemical Development,
Vertex Pharmaceuticals, Inc.,
"Development of Plant Manufacturing Processes of Key Intermediates for HCV Drug Candidate Telaprevir," Gerald J. Tanoury, Chemical Development, Vertex Pharmaceuticals, Inc.
For more information, please contact Arleen (Lynne) Martinez by phone at 4004 or by email at [email protected].
Event Series
Special Organic Chemistry Seminar Series